ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
157 hedge funds and large institutions have $2.27B invested in ANACOR PHARMACEUTICALS INC COM in 2015 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 57 reducing their positions, and 23 closing their positions.
416% more call options, than puts
Call options by funds: $51.9M | Put options by funds: $10M
75% more capital invested
Capital invested by funds: $1.29B → $2.27B (+$977M)
48% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 23
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
7% more funds holding
Funds holding: 147 → 157 (+10)
5% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 57
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.8M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$31.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.3M |
| 4 |
Jennison Associates
New York
|
+$18.4M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$18.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$50.5M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$31.9M |
| 3 |
CCM
Consonance Capital Management
New York
|
-$27.2M |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$22.1M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$20.9M |
ANAC Hedge Fund Activity: Q1 2015 in Review
157 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q1 2015, worth a combined $2.27B — up 75% from $1.29B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new ANAC positions and 23 closed out — a net gain of 11 holders — while 54 added to existing stakes and 57 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $31.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $50.5M sold.
- 157 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q1 2015, up from 147 in Q4 2014.
- Funds reported $2.27B of ANACOR PHARMACEUTICALS INC COM stock for Q1 2015, up 75% quarter-over-quarter.
- 34 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q1 2015 and 23 closed out, a net change of +11 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q1 2015 was Fidelity Investments, an estimated $31.8M added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q1 2015 was Point72 Asset Management, an estimated $50.5M sold.
Based on aggregated 13F filings for Q1 2015.